Registered Owners
- View profile →
PERUSAHAAN INDUSTRI FARMASI DAN DAGANG FIRST MEDIPHARMA - INDONESIA
KAB. SIDOARJO
NPWP: 011221314641000
owner
Direktorat Registrasi ObatValid
GENTAMICIN SULFATE
- BPOM Number
- GKL1007119730A1
- Approved
- 9 June 2026
- Expiry
- 29 April 2030
- Form
- Ointment
About This Registration
GENTAMICIN SULFATE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL1007119730A1. Its current registration status is Valid, with the licence valid until 29 April 2030. The product is registered to PERUSAHAAN INDUSTRI FARMASI DAN DAGANG FIRST MEDIPHARMA - INDONESIA. BPOM first approved this registration in June 2026. All registration data is sourced directly from the official BPOM public database and updated daily.
Registration Details
- Application
- newaero
- Packaging
- DUS, 1 TUBE @ 5 G
- Department
- Direktorat Registrasi Obat
Retail Audit Service
Get detailed market intelligence for this product across Indonesian retail channels
Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?
Stock availability and positioning verification
Price checking and competitor analysis
Display quality and promotional material assessment
Store condition and customer experience evaluation
Custom questions tailored to your research needs
Professional photographs and detailed reports
Manufacturing Sites
- View profile →
PERUSAHAAN INDUSTRI FARMASI DAN DAGANG FIRST MEDIPHARMA - INDONESIA
KAB. SIDOARJO
primary
Ingredients (1)
GENTAMICIN SULFATE
Market Intelligence
- Owner Portfolio
- PERUSAHAAN INDUSTRI FARMASI DAN DAGANG FIRST MEDIPHARMA - INDONESIA holds 101 BPOM registrations
- Manufacturer Scale
- PERUSAHAAN INDUSTRI FARMASI DAN DAGANG FIRST MEDIPHARMA - INDONESIA produces 101 registered products
- Registration Age
- Registered for 1 month
- Update Status
- Recently updated (38 days ago)
FDA Cross-Reference
via openFDA- Generic Name
- GENTAMICIN SULFATE
- Product Type
- HUMAN PRESCRIPTION DRUG
- Route of Administration
- INTRAMUSCULAR
Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.
Is this your product?
Claim it to manage registration, track renewals, and get expiry alerts.